Sign up to The Irish Times Archive (1859 - 2008)My Account »

Fri 04 Apr 2007Injection of hopeCroesus/An Investor's View:On Tuesday, Elan Pharmaceuticals reported its first-quarter figures, which were mixed relative to expectations.Losses for the quarter were much higher, at $93 million (€68 million) compared with $33 million in the same quarter last year. Some of the deterioration was due to a once- off charge of $18.8 million on debt retirement. Revenues of $176 million were close to expectations and comfortably higher than the $134 million achieved during the first quarter last year.